Treatment of antineutrophil cytoplasmic antibodyassociated vasculitis with rituximab

Rodrigo Cartin-Cebaa; Fernando C. Fervenzab; Ulrich Specks

doi:10.1097/BOR.0b013e32834d5730

Treatment of antineutrophil cytoplasmic antibodyassociated vasculitis with rituximab

Rodrigo Cartin-Cebaa, Fernando C. Fervenzab, Ulrich Specks

Pulmonary and Critical Care Medicine

Research output: Contribution to journal › Review article › peer-review

35 Scopus citations

Abstract

RTX is the first proven alternative to CYC for remission induction in severe GPA and MPA. RTX is the preferred agent for patients presenting with severe disease flares, and its use had become the de facto standard of care for patients with chronically relapsing refractory GPA. Its use in EGPA requires further investigation.

Original language	English (US)
Pages (from-to)	15-23
Number of pages	9
Journal	Current opinion in rheumatology
Volume	24
Issue number	1
DOIs	https://doi.org/10.1097/BOR.0b013e32834d5730
State	Published - Jan 2012

Keywords

Antineutrophil cytoplasmic antibody
Antineutrophil cytoplasmic antibody associated vasculitis
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
Granulomatosis with polyangiitis (Wegener's granulomatosis)
Microscopic polyangiitis
Rituximab
Vasculitis

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1097/BOR.0b013e32834d5730

Cite this

@article{3c2bed8626d44e1fa324a92d43b6f139,

title = "Treatment of antineutrophil cytoplasmic antibodyassociated vasculitis with rituximab",

abstract = "RTX is the first proven alternative to CYC for remission induction in severe GPA and MPA. RTX is the preferred agent for patients presenting with severe disease flares, and its use had become the de facto standard of care for patients with chronically relapsing refractory GPA. Its use in EGPA requires further investigation.",

keywords = "Antineutrophil cytoplasmic antibody, Antineutrophil cytoplasmic antibody associated vasculitis, Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), Granulomatosis with polyangiitis (Wegener's granulomatosis), Microscopic polyangiitis, Rituximab, Vasculitis",

author = "Rodrigo Cartin-Cebaa and Fervenzab, {Fernando C.} and Ulrich Specks",

year = "2012",

month = jan,

doi = "10.1097/BOR.0b013e32834d5730",

language = "English (US)",

volume = "24",

pages = "15--23",

journal = "Current opinion in rheumatology",

issn = "1040-8711",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Treatment of antineutrophil cytoplasmic antibodyassociated vasculitis with rituximab

AU - Cartin-Cebaa, Rodrigo

AU - Fervenzab, Fernando C.

AU - Specks, Ulrich

PY - 2012/1

Y1 - 2012/1

N2 - RTX is the first proven alternative to CYC for remission induction in severe GPA and MPA. RTX is the preferred agent for patients presenting with severe disease flares, and its use had become the de facto standard of care for patients with chronically relapsing refractory GPA. Its use in EGPA requires further investigation.

AB - RTX is the first proven alternative to CYC for remission induction in severe GPA and MPA. RTX is the preferred agent for patients presenting with severe disease flares, and its use had become the de facto standard of care for patients with chronically relapsing refractory GPA. Its use in EGPA requires further investigation.

KW - Antineutrophil cytoplasmic antibody

KW - Antineutrophil cytoplasmic antibody associated vasculitis

KW - Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)

KW - Granulomatosis with polyangiitis (Wegener's granulomatosis)

KW - Microscopic polyangiitis

KW - Rituximab

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=82955227492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82955227492&partnerID=8YFLogxK

U2 - 10.1097/BOR.0b013e32834d5730

DO - 10.1097/BOR.0b013e32834d5730

M3 - Review article

C2 - 22089095

AN - SCOPUS:82955227492

SN - 1040-8711

VL - 24

SP - 15

EP - 23

JO - Current opinion in rheumatology

JF - Current opinion in rheumatology

IS - 1

ER -

Treatment of antineutrophil cytoplasmic antibodyassociated vasculitis with rituximab

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this